Virtus ETF Advisers’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,534
| Closed | -$102K | – | 457 |
|
|
2023
Q3 | $102K | Sell |
16,534
-1,650
| -9% | -$10.1K | 0.06% | 333 |
|
|
2023
Q2 | $114K | Buy |
18,184
+7,762
| +74% | +$48.6K | 0.07% | 335 |
|
|
2023
Q1 | $49.7K | Sell |
10,422
-4,003
| -28% | -$19.1K | 0.03% | 430 |
|
|
2022
Q4 | $125K | Buy |
14,425
+3,364
| +30% | +$29.3K | 0.07% | 404 |
|
|
2022
Q3 | $132K | Buy |
11,061
+75
| +0.7% | +$895 | 0.05% | 376 |
|
|
2022
Q2 | $157K | Buy |
10,986
+4,240
| +63% | +$60.6K | 0.06% | 316 |
|
|
2022
Q1 | $140K | Sell |
6,746
-405
| -6% | -$8.41K | 0.06% | 237 |
|
|
2021
Q4 | $165K | Buy |
7,151
+922
| +15% | +$21.3K | 0.06% | 310 |
|
|
2021
Q3 | $186K | Sell |
6,229
-327
| -5% | -$9.76K | 0.08% | 285 |
|
|
2021
Q2 | $224K | Buy |
+6,556
| New | +$224K | 0.09% | 263 |
|